VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ALGS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ALGSAligos Therapeutics, Inc.
$1.30$8M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksALGSQuarterly Cash Flow

Aligos Therapeutics, Inc. (ALGS) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Aligos Therapeutics, Inc. (ALGS) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

ALGS Cash Flow Statement

Quarterly statement

ALGS Cash Flow Statement

Aligos Therapeutics, Inc. (ALGS) cash flow statement — 8-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations1.45M-24.95M-23.13M-21.75M-24.34M-15.5M-20.91M-18.4M-20.1M-19.49M-22.75M-22.66M-20.34M-13.62M-22.39M-16.78M-17.14M-25.04M-20.43M-37.48M
Operating CF Margin %50.58%-89.82%-817.24%-12866.86%-3285.43%-1606.63%-6723.15%-2925.76%-1584%-1837.23%-2306.9%-845.13%-627.85%-197.73%-822.14%-474.5%-417.36%-677.9%-794.79%-10212.53%
Operating CF Growth %105.96%-60.93%-10.61%-18.16%-21.11%20.46%8.08%18.78%1.16%-43.16%-1.6%-35.01%-18.67%45.61%-9.56%55.22%32.45%-7.35%30.72%-90.41%
Net Income-21.86M-1.5M-23.04M-19.88M-31.54M-15.86M43.09M-82.15M-19.26M5.06M-34.86M-27.89M-18.04M-18.79M-22.95M-21.89M-18.62M-19.92M-35.62M-37.71M
Depreciation & Amortization681K255K346K749K698K848K510K671K667K610K674K775K681K769K844K897K906K889K983K1.01M
Stock-Based Compensation1.28M1.36M1.31M1.46M1.47M1.16M959K1.71M2.04M2.06M2.65M2.58M3.21M3.2M3.66M3.42M3.49M4M3.79M3.65M
Deferred Taxes00000000000000000000
Other Non-Cash Items-189K-2.58M-3.31M-1.66M3.5M-2.58M-61.63M61.76M-370K-31.33M14.29M2.17M17K567K-267K-75K-69K-24K9K23K
Working Capital Changes21.54M-22.49M1.56M-2.41M1.53M930K-3.83M-390K-3.18M4.11M-5.49M-293K-6.2M643K-3.67M865K-2.84M-9.98M10.4M-4.45M
Change in Receivables27.78M0000000000000000000
Change in Inventory00000000000000000000
Change in Payables-3.22M-1.21M3.66M-669K752K-402K1.73M-169K-4.08M3.98M325K-423K-300K419K-1.92M1.81M169K-993K740K399K
Cash from Investing-127K25M34.93M-2.02M47.68M-39.42M-44.07M19.97M10.4M39.99M-88.64M-7K-9K25M19.99M11.6M32.48M-9.98M-60.4M-16.48M
Capital Expenditures-127K-1K-69K-92K-193K-109K-43K-28K-26K-7K-69K-7K-12K7K-7K-91K-3K-334K-515K-336K
CapEx % of Revenue4.43%0%2.44%54.44%26.05%11.3%13.83%4.45%2.05%0.66%7%0.26%0.37%0.1%0.26%2.57%0.07%9.04%20.03%91.55%
Acquisitions000000000000-7K7K00-32.49M000
Investments--------------------
Other Investing000000000000000032.49M000
Cash from Financing-8K220K-62K123K-53K-177K101.74M97K-4K281K-19K87.94M-21K414K-1K121K-19K83K-21K552K
Debt Issued (Net)-8K-78K-62K-3K-10K-1K0-43K-5K-16K-19K-4K-21K-47K-24K27K-28K-29K-31K-20K
Equity Issued (Net)0236K0-101.22M101.34M-356K101.74M140K1K297K087.94M0461K23K94K9K112K10K0
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing062K0101.34M-101.39M180K0000000000000572K
Net Change in Cash1.32M269K11.74M-23.64M23.29M-55.1M36.77M1.67M-9.71M20.78M-111.41M65.27M-20.37M11.8M-2.39M-5.06M15.33M-34.93M-80.86M-53.41M
Free Cash Flow1.32M-24.95M-23.2M-21.84M-24.54M-15.61M-20.95M-18.43M-20.13M-19.5M-22.82M-22.66M-20.35M-13.61M-22.39M-16.87M-17.14M-25.37M-20.95M-37.82M
FCF Margin %46.15%-89.82%-819.68%-12921.3%-3311.47%-1617.93%-6736.98%-2930.21%-1586.05%-1837.89%-2313.89%-845.39%-628.22%-197.63%-822.4%-477.07%-417.44%-686.95%-814.82%-10304.09%
FCF Growth %105.4%-59.81%-10.71%-18.48%-21.92%19.93%8.17%18.68%1.09%-43.29%-1.88%-34.32%-18.72%46.36%-6.9%55.38%32.69%-8.08%29.7%-91.52%
FCF per Share0.13-2.39-2.23-2.10-2.37-1.51-2.41-2.93-3.21-3.11-1.47-0.91-0.47-0.31-0.52-0.39-0.40-0.59-0.49-0.89
FCF Conversion (FCF/Net Income)-0.07x16.59x1.00x1.09x0.77x0.98x-0.49x0.22x1.04x-3.85x0.65x0.81x1.13x0.72x0.98x0.77x0.92x1.26x0.57x0.99x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000